Skip to main content
. 2014 Apr;26(2):192–199. doi: 10.3978/j.issn.1000-9604.2014.04.06

Table 3. Overall survival related to clinicopathological features of EGC patients.

Clinicopathological features Patients (n) Events (n) 5-year OS rate 10-year OS rate P
Gender 0.097
   Male 156 16 0.930 0.775
   Female 70 3 0.971 0.901
Age (year) 0.128
   <60 115 6 0.964 0.912
   360 111 13 0.921 0.744
Tumor location 0.434
   Upper 1/3 31 1 0.968 0.968
   Middle 1/3 61 5 0.951 0.841
   Lower 1/3 134 13 0.943 0.771
Macroscopic type 0.274
   I/II 147 10 0.949 0.851
   III/Mixed 79 9 0.931 0.771
Size (cm) 0.023
   <2.0 106 5 0.958 0.918
   32.0 120 14 0.941 0.687
Histology 0.714
   Adenocarcinoma 160 13 0.947 0.826
   Other types* 66 6 0.929 0.800
Differentiation 0.589
   Differentiated 100 10 0.946 0.786
   Undifferentiated 126 9 0.939 0.858
Ulcer 0.734
   Absent 193 16 0.951 0.835
   Present 33 3 0.938 0.626
Lymphovascular invasion 0.279
   Absent 204 16 0.958 0.816
   Present 22 3 0.864 0.864
Depth of invasion 0.459
   Mucosa 127 12 0.932 0.858
   Submucosa 99 7 0.970 0.775
Lymph node metastasis
   No 209 13 0.969 0.856 0.000
   Yes 17 6 0.688 0.458
   N0-1 220 14 0.964 0.838 0.000
   N2-3 6 5 0.167 0.167

EGC, early gastric cancer; OS, overall survival; *, signet-ring cell carcinoma, mucinous adenocarcinoma and et al.